Sugi Predict

Sugi Predict / Compounds / SCHEMBL2000134

SCHEMBL2000134

SCHEMBL2000134

Cc1ccc2c(c1)c(C(=O)c1nc(-c3ccccc3)no1)c(Cl)n2Cc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ FAAH O00519 1/20 0.42
▸ CNR2 P34972 2/20 0.42
▸ PTGES2 Q9H7Z7 3/20 0.42
▸ PTGES O14684 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 5/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ DRD2 P14416 2/20 0.40
▸ SMPD1 P17405 1/20 0.39
▸ TP53 P04637 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2003986 0.92 TP53 (0.47) KMT2AMEN1HTTFAAHSMN1; SMN2
SCHEMBL2004796 0.91 CYP1A2 (0.45) KMT2AMEN1HTTFAAHPTGES2
SCHEMBL2003213 0.90 MAPT (0.40) HTTCNR2SMN1; SMN2MAPK1RAB9A
SCHEMBL2001742 0.89 PLA2G2A (0.48) KMT2AMEN1SMN1; SMN2MAPK1ALDH1A1
SCHEMBL2004495 0.89 FAAH (0.46) KMT2AMEN1HTTFAAHPTGES2
SCHEMBL2001026 0.89 ALDH1A1 (0.44) KMT2AMEN1CNR2PTGES2SMN1; SMN2
SCHEMBL2004420 0.88 FAAH (0.44) KMT2AMEN1HTTFAAHSMN1; SMN2
SCHEMBL2000496 0.88 FAAH (0.42) KMT2AMEN1HTTFAAHPTGES2
SCHEMBL2008317 0.85 FAAH (0.41) KMT2AMEN1HTTFAAHPTGES2
SCHEMBL2005819 0.84 MEN1 (0.43) KMT2AMEN1HTTFAAHCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 — — EP disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT KMT2A 2169/4885MEN1 2374/4885HTT 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.